Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 may prevent hair loss caused by chemotherapy.

The 2012 criteria are better for diagnosing atypical lupus cases.

An 87-year-old man showed unusual signs of Hodgkin lymphoma, primarily high calcium levels, which improved after treatment and revealed the disease.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

RHUPUS should be considered in children with deforming arthritis.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

Axitinib treatment turned a man's grey hair back to black.

Autoimmune reactions may cause both alopecia areata and HAM.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

A kidney transplant patient developed pink skin bumps with spiny centers on her face and limbs.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Autoimmune diseases need combined therapy of tolerance induction and immunosuppression.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Alopecia areata involves unique activation of certain immune cells.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

A 30-year-old man with rare skin conditions improved with antibiotics and surgery, hinting at a link to rosacea.